TNF

Treatment-Resistant Psoriatic Arthritis Improved by Ixekizumab

Treatment-Resistant Psoriatic Arthritis Improved by Ixekizumab

Ixekizumab benefits patients with treatment-resistant psoriatic arthritis when administered over a 2- or 4-week period.

Neurostimulation to Target the Inflammatory Reflex in Rheumatoid Arthritis

Neurostimulation to Target the Inflammatory Reflex in Rheumatoid Arthritis

By

Vagus nerve stimulation inhibits cytokine production and reduces inflammation, and may be effective for a subset of RA patients.

Sign Up for Free e-Newsletters